Varegacestat for Progressing Desmoid Tumors

Varegacestat for Progressing Desmoid Tumors
100%75%50%25%0%May 20May 21May 21 18:16 UTC • YES 55.0%May 21 18:52 UTC • YES 55.0%May 21 18:53 UTC • YES 61.8%
ResolvedPositive
Oracle Evidence
ClinicalNewsTrialPositionsReasoningOracle
Resolved Date
5/28/26
Study Completion
10/1/26
Sponsor
Immunome, Inc.
Ticker
$IMNM
Type
Phase 2/Phase 3
Trial Status
Active Not Recruiting
Trial Size
198
NCT
NCT04871282
Trial Description
This study tests varegacestat for people with progressing desmoid tumors, measuring how long tumors stay from worsening.